A detailed history of Palouse Capital Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Palouse Capital Management, Inc. holds 19,101 shares of INCY stock, worth $1.34 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
19,101
Previous 19,101 -0.0%
Holding current value
$1.34 Million
Previous $1.26 Million -0.0%
% of portfolio
0.82%
Previous 0.82%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$57.33 - $68.61 $29,180 - $34,922
-509 Reduced 2.6%
19,101 $1.26 Million
Q2 2024

Aug 12, 2024

SELL
$51.18 - $63.75 $16,019 - $19,953
-313 Reduced 1.57%
19,610 $1.19 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $1.13 Million - $1.33 Million
19,923 New
19,923 $1.14 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Palouse Capital Management, Inc. Portfolio

Follow Palouse Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palouse Capital Management, Inc. with notifications on news.